Cancer Policy: Pharmaceutical Safety

Front Matter ....Pages i-v
 Impact of Cost on the Safety of Cancer Pharmaceuticals  (Karen Fitzner, Frederick Oteng-Mensah)....Pages 1-20
 Cancer Comorbidity: Implications for Drug Safety  (Katherine O’Brien, June M. McKoy, Frank Penedo)....Pages 21-35
 Pharmacovigilance of Alternative Medications in the Cancer Setting  (Dustin B. Liebling, Emmanuel Cordova, Gary Deng, June M. McKoy)....Pages 37-45
 Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies  (Brian Chen, John Restaino, Elizabeth Tippett)....Pages 47-59
 Biosimilars: Are They Really Safe?  (June M. McKoy, Frank J. Giles)....Pages 61-73
 The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety  (Narissa J. Nonzee, Thanh Ha Luu)....Pages 75-92
 Anatomy of Risk Evaluation and Mitigation Strategies (REMS)  (Kari K. Loeser, June M. McKoy, Glen T. Schumock)....Pages 93-105
 Cancer Drug Toxicity: Moving from Patient to Survivor  (Megan Slocum, Sophie F. Garcia, June M. McKoy)....Pages 107-118
 Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos  (Melissa Simon, Emmanuel Cordova, June M. McKoy)....Pages 119-128